Hostname: page-component-8448b6f56d-jr42d Total loading time: 0 Render date: 2024-04-23T14:09:09.943Z Has data issue: false hasContentIssue false
  • English
  • Français

Resource Consumption in the Infection Control Management of Pertussis Exposure Among Healthcare Workers in Pediatrics

Published online by Cambridge University Press:  02 January 2015

Irini Daskalaki ,
Patricia Hennessey ,
Robin Hubler  and
Sarah S. Long
Irini Daskalaki*
Affiliation:
Department of Pediatrics, Drexel University College of Medicine, Philadelphia, Pennsylvania Infection Control Program, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania
Patricia Hennessey
Affiliation:
Infection Control Program, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania
Robin Hubler
Affiliation:
Infection Control Program, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania
Sarah S. Long
Affiliation:
Department of Pediatrics, Drexel University College of Medicine, Philadelphia, Pennsylvania Infection Control Program, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania
*
Section of Infectious Diseases, Department of Pediatrics, St. Christopher's Hospital for Children, Erie Avenue at Front Street, Philadelphia, PA 19134 (idaskala@drexelmed.edu)
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To assess consumption of resources in the infection control management of healthcare workers (HCWs) exposed to pertussis and to assess avoidability of exposure.

Setting.

Tertiary care children's medical center.

Methods.

Analysis of the extent of and reasons for HCW exposure to pertussis during contact with children with the disease, whether exposures were avoidable (because of the failure to recognize a case or to order or adhere to isolation precautions) or unavoidable (because the case was not recognizable or because another diagnosis was confirmed), and the cost of implementing exposure management.

Interventions.

Interventions consisted of an investigation of every HCW encounter with any patient who was confirmed later to have pertussis from the time of hospital admission of the patient, use of azithromycin as postexposure prophylaxis (PEP) for exposed HCWs, performance of 21-day surveillance for cough illness, testing of symptomatic exposed HCWs for Bordetella pertussis, and enhanced preexposure education of HCWs.

Results.

From September 2003 through April 2005, pertussis was confirmed in 28 patients (median age, 62 days); 24 patients were admitted. For 11 patients, pertussis was suspected, appropriate precautions were taken, and no HCW was exposed. Inadequate precautions for 17 patients led to 355 HCW exposures. The median number of HCWs exposed per exposing patient was 9 (range, 1-86 HCWs; first quartile mean, 2; fourth quartile mean, 61). Exposure was definitely avoidable for only 61 (17%) of 355 HCWs and was probably unavoidable for 294 HCWs (83%). The cost of 20-month infection control management of HCWs exposed to pertussis was $69,770. The entire cohort of HCWs involved in direct patient care at the facility could be immunized for approximately $60,000.

Conclusions.

Exposure of HCWs to pertussis during contact with children who have the disease is largely unavoidable, and management of this exposure is resource intensive. Universal preexposure vaccination of HCWs is a better utilization of resources than is case-based postexposure management.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 4 , April 2007 , pp. 412 - 417
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Centers for Disease Control and Prevention. National, state and urban area vaccination coverage among children aged 19-35 months—United States 2004. MMWR Morb Mortal Wkly Rep 2005;54:717–721.Google Scholar
2.Bisgard, KM, Pascual, FB, Ehresmann, KR, et al.Infant pertussis: who was the source? Pediatr Infect Dis J 2004;23:985–989.CrossRefGoogle ScholarPubMed
3.Vitek, CR, Pascual, FB, Baughman, AL, Murphy, TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003;22:628–634.CrossRefGoogle ScholarPubMed
4.Halasa, NB, Barr, FE, Johnson, JE, Edwards, KM. Fatal pulmonary hypertension associated with pertussis in infants: does extracorporeal membrane oxygenation have a role? Pediatrics 2003;112:1274–1278.CrossRefGoogle ScholarPubMed
5.Mikelova, LK, Halperin, SA, Scheifele, D, et al.Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada. J Pediatr 2003;143:576–581.CrossRefGoogle ScholarPubMed
6.Baptista, PN, Magalkaes, V, Rodrigues, LC, Rocha, MA, Pimentel, AM. Pertussis vaccine effectiveness in reducing clinical disease, transmissibility and bacteriologically positive cases after household exposure in Brazil. Pediatr Infect Dis J 2006;25:844–846.CrossRefGoogle ScholarPubMed
7.Long, SS, Fisher, MC, Mortensen, JE, Deforest, A. Epidemiology of pertussis in Philadelphia. In: Manclark, CR, ed. Proceedings of the Sixth International Symposium on Pertussis. Bethesda, MD: Department of Health and Human Services; 1990:335–342.Google Scholar
8.Farizo, KM, Cochi, SL, Zell, ER, Brink, EW, Wassilak, SG, Patriarca, PA. Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis 1992;14:708–719.CrossRefGoogle ScholarPubMed
9.Centers for Disease Control and Prevention. Guidelines for the Control of Pertussis Outbreaks. Atlanta, GA: Centers for Disease and Prevention; 2000. Available at: http://www.cdc.gov/nip/publications/pertussis/guide.htm. Accessed March 9, 2007.Google Scholar
10.Gilligan, PH, Fisher, MC. Importance of culture in laboratory diagnosis of Bordetella pertussis infections. J Clin Microbiol 1984;20:891–893.CrossRefGoogle ScholarPubMed
11.Calugar, A, Ortega-Sanchez, IR, Tiwari, T, Oakes, L, Jahre, JA, Murphy, T. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 2006;42:981–988.CrossRefGoogle ScholarPubMed
12.Kurt, TL, Yeager, AS, Guenette, S, Dunlop, S. Spread of pertussis by hospital staff. JAMA 1972;221:264–267.CrossRefGoogle ScholarPubMed
13.Linneman, CC, Ramundo, N, Perlstein, PH, Minton, SD, Englender, GS. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975;2:540–543.CrossRefGoogle Scholar
14.Fisher, MC, Long, SS, McGowan, KL, Kaselis, E, Smith, DG. Outbreak of pertussis in a residential facility for handicapped people. J Pediatr 1989;114:934–939.CrossRefGoogle Scholar
15.Gehanno, JF, Pestel-Caron, M, Nouvellon, M, Caillard, JF. Nosocomial pertussis in healthcare workers from a pediatric emergency unit in France. Infect Control Hosp Epidemiol 1999;20:549–552.CrossRefGoogle ScholarPubMed
16.Martinez, SM, Kemper, CA, Haiduven, D, Cody, SH, Deresinski, SC. Azithromycin prophylaxis during hospitalwide outbreak of a pertussis-like illness. Infect Control Hosp Epidemiol 2001;22:781–783.CrossRefGoogle ScholarPubMed
17.Christie, CDC, Glover, AM, Willke, MJ, Marx, ML, Reising, SF, Hutchinson, NM. Containment of pertussis in the regional pediatric hospital during the Greater Cincinnati epidemic of 1993. Infect Control Hosp Epidemiol 1995;16:556–563.CrossRefGoogle ScholarPubMed
18.Friedman, DS, Curtis, R, Schauer, SL, et al.Surveillance for transmission and antibiotic adverse events among neonates and adults exposed to a healthcare worker with pertussis. Infect Control Hosp Epidemiol 2004;25:967–973.CrossRefGoogle ScholarPubMed
19.Bassinet, L, Matrat, M, Njamkepo, E, Aberrane, S, Housset, B, Guiso, N. Nosocomial pertussis outbreak among adult patients and healthcare workers. Infect Control Hosp Epidemiol 2004;25:995–997.CrossRefGoogle ScholarPubMed
20.Ward, A, Caro, J, Bassinet, L, Housset, B, O'Brien, JA, Guiso, N. Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France. Infect Control Hosp Epidemiol 2005;26:288–292.CrossRefGoogle Scholar
21.Boulay, BR, Murray, CJ, Ptak, J, Kirkland, KB, Montero, J, Talbot, EA. An outbreak of pertussis in a hematology-oncology care unit: implications for adult vaccination policy. Infect Control Hosp Epidemiol 2006;27:92–95.CrossRefGoogle Scholar
22.Spearing, NM, Horvath, RL, McCormack, JK. Pertussis: adults as a source in healthcare settings. Med J Aust 2002;177:568–569.CrossRefGoogle ScholarPubMed
23.Lane, NE, Paul, RI, Bratcher, DF, Stover, BH. A survey of policies at children's hospitals regarding immunity of healthcare workers: are physicians protected? Infect Control Hosp Epidemiol 1997;18:400–404.CrossRefGoogle ScholarPubMed
24.Weber, DJ, Rutala, WA. Pertussis: a continuing hazard for healthcare facilities. Infect Control Hosp Epidemiol 2001;22:736–740.CrossRefGoogle ScholarPubMed
25.Shefer, A, Dales, L, Nelson, M, Werner, B, Bron, R, Jackson, R. Use and safety of acellular pertussis vaccine among adult hospital staff during an outbreak of pertussis. J Infect Dis 1995;171:1053–1056.CrossRefGoogle ScholarPubMed
26.Christie, CDC, Garrison, KM, Kiely, L, Gupta, RK, Heubi, J, Marchant, CD. A trial of acellular pertussis vaccine in hospital workers during the Cincinnati pertussis epidemic of 1993. Clin Infect Dis 2001;33:997–1003.CrossRefGoogle ScholarPubMed
27.van der Zee, A, Agterberg, C, Peeters, M, Mooi, F, Schellekens, J. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J Infect Dis 1996;174:89–96.CrossRefGoogle ScholarPubMed
28.MuUer, FM, Hoppe, JE, Wirsing von Konig, CH. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997;35:2435–2443.Google Scholar
29.American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics 2006;117:965–978.CrossRefGoogle Scholar
30.Centers for Disease Control and Prevention. Preventing tetanus, diphtheria and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of the ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among healthcare personnel. MMWR Morb Mortal Wkly Rep 2006;55(RR-17):1–33.Google Scholar
31.Ward, JI, Cherry, JD, Chang, SJ, et al.Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005;353:1555–1563.CrossRefGoogle ScholarPubMed